715 related articles for article (PubMed ID: 10370699)
41. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
42. [The treatment of gastric carcinoma in III stage].
Lin C; Zhu X; Chai Z
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):548-50. PubMed ID: 8731875
[TBL] [Abstract][Full Text] [Related]
43. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
Samel S; Singal A; Becker H; Post S
Eur J Surg Oncol; 2000 Apr; 26(3):222-6. PubMed ID: 10753533
[TBL] [Abstract][Full Text] [Related]
44. [A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
Yamamura Y; Miyazaki I; Ogawa M; Yonemura Y; Tanemura H; Kito T; Hamajima N; Saji S; Kosaka T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1543-8. PubMed ID: 9725047
[TBL] [Abstract][Full Text] [Related]
45. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
46. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
47. Postoperative chemotherapy may improve prognosis in unresectable gastric cancer.
Hanazaki K; Sodeyama H; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Otsuka M
J Clin Gastroenterol; 1998 Jun; 26(4):269-73. PubMed ID: 9649009
[TBL] [Abstract][Full Text] [Related]
48. The significance of gastrectomy in advanced gastric cancer patients with non-curative factors.
Miyagaki H; Fujitani K; Tsujinaka T; Hirao M; Yasui M; Kashiwazaki M; Ikenaga M; Miyazaki M; Mishima H; Nakamori S
Anticancer Res; 2008; 28(4C):2379-84. PubMed ID: 18751422
[TBL] [Abstract][Full Text] [Related]
49. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].
Kosaka T; Ueshige N; Sugaya J; Nakano Y; Akiyama T; Tomita F; Saito H; Kita I; Takashima S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1288-91. PubMed ID: 9703810
[TBL] [Abstract][Full Text] [Related]
51. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer--(Part 2). Comparisons between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Kuroda Y; Arima S; Ohsato K; Ohkuma R; Fukuyama N; Yamanouchi A; Hisatsugu T; Yamamoto H; Nakamura Y; Abe R
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2235-40. PubMed ID: 2500069
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors.
Kunieda K; Saji S; Sugiyama Y; Osada S; Sano J; Nagao N; Takahashi T; Takagi Y; Arai Y
Surg Today; 2002; 32(7):587-93. PubMed ID: 12111514
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
[TBL] [Abstract][Full Text] [Related]
55. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.
Hartgrink HH; van de Velde CJ; Putter H; Songun I; Tesselaar ME; Kranenbarg EK; de Vries JE; Wils JA; van der Bijl J; van Krieken JH;
Eur J Surg Oncol; 2004 Aug; 30(6):643-9. PubMed ID: 15256239
[TBL] [Abstract][Full Text] [Related]
56. [End result of preoperative adjuvant chemotherapy with oral 5-FU dry syrup in gastric cancer].
Miyamoto Y; Izuo M; Takeshita M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1929-33. PubMed ID: 3382242
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
Takada J; Katsuki Y; Hamada H; Tsuji Y
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1627-30. PubMed ID: 14619480
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
59. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
60. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
